DNA adduct formation, removal and persistence in rat liver during one month of feeding 2-acetylaminofluorene. 1984

M C Poirier, and J M Hunt, and B A True, and B A Laishes, and J F Young, and F A Beland

Male Wistar-Furth rats were fed 0.02% 2-acetylaminofluorene (AAF) for 3 days or 0.02% AAF for 25 days followed by 0.02% [ring-3H]AAF for an additional 3 days. The concentration of hepatic DNA adducts was then monitored by both radioimmunoassay and radiolabeling during 28 days of control diet. This approach allowed comparisons to be made of adduct accumulation, removal and persistence at both the beginning and end of a four week carcinogen feeding period. DNA adduct formation remained constant during the month of AAF administration with an accumulation rate of 157 fmol adduct/micrograms DNA during days 1-3 and days 25-28 of the experiment. Furthermore, the rate of removal of adducts formed during these three day periods was similar when both groups were fed control diets for 28 additional days. Continued AAF administration resulted in a slow accumulation of persistent adducts; thus, 91 +/- 6% of the adducts detected after 3 days of AAF feeding were removed during a subsequent month of control diet, while only 65 +/- 11% of the adducts detected after 28 days of AAF diet were removed when rats were fed control diet for an additional 28 days. In a second experiment, the removal of adducts was compared in animals fed control or AAF diet after previously being fed 0.02% AAF for 17 days. Similar removal curves were observed in both groups; therefore, continued ingestion of AAF did not affect the rate of adduct removal. In both experiments, biphasic repair curves were observed. These data were used to develop a pharmacokinetic model. Two genomic regions were postulated, an area susceptible to fast repair and a region more resistant to the removal of AAF adducts. At equilibrium, which was reached after 2-3 weeks of AAF feeding, the concentration of adducts in each region was similar with approximately 150 fmol adduct/micrograms DNA. Although the total number of adducts formed in the fast repair region during one month of AAF administration was five times greater than in the resistant region, the model predicted that the adducts localized in regions resistant to repair were the persistent adducts detected after one month of control diet. Overall, the removal of adducts formed during chronic AAF feeding was very efficient since greater than 93% of the adducts were removed by the end of a subsequent month of control diet.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015073 2-Acetylaminofluorene A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines. 2-Acetamidofluorene,Fluoren-2-ylacetamide,2-AAF,2-Fluorenylacetamide,AAF, Aminofluorene,Acetylaminofluorene,N-2-Fluorenylacetamide,N-Acetyl-2-Aminofluorene,2 Acetamidofluorene,2 Acetylaminofluorene,2 Fluorenylacetamide,Aminofluorene AAF,Fluoren 2 ylacetamide,N 2 Fluorenylacetamide,N Acetyl 2 Aminofluorene

Related Publications

M C Poirier, and J M Hunt, and B A True, and B A Laishes, and J F Young, and F A Beland
January 1988, IARC scientific publications,
M C Poirier, and J M Hunt, and B A True, and B A Laishes, and J F Young, and F A Beland
June 1989, Carcinogenesis,
M C Poirier, and J M Hunt, and B A True, and B A Laishes, and J F Young, and F A Beland
January 1983, Basic life sciences,
M C Poirier, and J M Hunt, and B A True, and B A Laishes, and J F Young, and F A Beland
August 1990, Carcinogenesis,
M C Poirier, and J M Hunt, and B A True, and B A Laishes, and J F Young, and F A Beland
November 1994, Carcinogenesis,
M C Poirier, and J M Hunt, and B A True, and B A Laishes, and J F Young, and F A Beland
April 1982, Cancer research,
M C Poirier, and J M Hunt, and B A True, and B A Laishes, and J F Young, and F A Beland
January 1990, Progress in clinical and biological research,
M C Poirier, and J M Hunt, and B A True, and B A Laishes, and J F Young, and F A Beland
March 1984, Carcinogenesis,
M C Poirier, and J M Hunt, and B A True, and B A Laishes, and J F Young, and F A Beland
October 1984, Carcinogenesis,
M C Poirier, and J M Hunt, and B A True, and B A Laishes, and J F Young, and F A Beland
October 1981, Biochimica et biophysica acta,
Copied contents to your clipboard!